Strategic Partnerships Zephyr Sleep Technologies has engaged in multiple non-exclusive co-marketing partnerships with dental and sleep organizations (Dental Sleep Solutions, Great Lakes Orthodontics, Seattle Study Club, Aurum Group) which suggests there is an ongoing channel expansion opportunity to broaden MATRx plus reach through allied providers and cross-selling.

ORB Clinical Validation MATRx plus is FDA approved and designed to identify obstructive sleep apnea and optimize oral appliance therapy, offering a three-visit workflow that can reduce appliance rework and shorten time-to-treatment, making it attractive for clinics seeking efficiency gains and better outcomes to pitch in sales conversations.

Home-First Model The home sleep test and theragnostic approach enables remote patient assessment and device prescription, which can appeal to telemedicine-adjacent practices and busy clinicians looking to expand OSA treatment offerings without extensive in-lab infrastructure.

Growth via Dental Channels Partnerships with dental-focused entities indicate a sales strategy that reaches dentists and orthodontists; we should target dental distributors, practice management groups, and DSO networks that could bundle MATRx plus with oral appliance therapies.

Market Readiness With a lean headcount and a stated revenue band indicating early-stage scale, there is a perceived upside for value-based selling, focus on training, and ROI demonstrations that highlight reduced rework, faster treatment initiation, and improved clinical efficiency to drive adoption.